Skip to main content
Top
Published in: Pituitary 1/2013

01-03-2013

Thyroid cancer in patients with acromegaly: a case–control study

Authors: Maíra Cristina Carvalho dos Santos, Gilvan Cortês Nascimento, Ana Gisélia Cortês Nascimento, Viviane Chaves Carvalho, Maria Honorina Cordeiro Lopes, Renan Montenegro, Renan Montenegro Jr., Lucio Vilar, Mônica Fiterman Albano, Alice Regina Vasconcelos Alves, Conceição Veiga Parente, Manuel dos Santos Faria

Published in: Pituitary | Issue 1/2013

Login to get access

Abstract

Several studies have associated acromegaly with an increased risk of benign and malignant tumors. While simple and multinodular goiters are common findings in acromegaly, the prevalence of thyroid cancer is uncertain. The objective of this study was to estimate the prevalence of thyroid cancer in a series of acromegalic patients from three hospitals in northeast of Brazil. The methodology used included morphological, cytological and histological thyroid analysis of acromegalic patients and volunteers over 18 years, matched for age and sex and with nodule (s) ≥1 cm. The subjects of this study were 124 acromegalic patients, including 76 females (61.3%) and 48 men (38.7%), with a mean age 45.1 years. Results of the study showed that thyroid ultrasonography was normal in 31 cases (25%), 25 had diffuse goiter (20.1%), 67 had nodules (54%) and one agenesis of the right lobe (0.8%). Thirty-six patients underwent fine needle aspiration biopsy (FNAB) of their nodules and 9 cases of papillary cancer were found (7.2%). The control group consisted of 263 subjects, 156 females (59.3%) and 107 males (40.7%), mean age 44.7 years. In ultrasound assessment, 96 had nodules (36.5%). Of these, 13 were punctured and 2 cases of papillary carcinoma were found (0.7%). These results gave an odds ratio of 10.21 (p = 0.0011, 95% CI 2.17 to 48.01). These findings demonstrate an increased prevalence of thyroid cancer, statistically significant when compared to our control group. Thus, it is suggested that acromegalic patients should be routinely submitted to thyroid ultrasound evaluation, followed by FNAB of nodules when indicated.
Literature
1.
go back to reference Clayton PE, Banerjee I, Murray PG, Renehan AG (2011) Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 7:11–24PubMedCrossRef Clayton PE, Banerjee I, Murray PG, Renehan AG (2011) Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 7:11–24PubMedCrossRef
3.
go back to reference Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152PubMedCrossRef Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152PubMedCrossRef
4.
go back to reference Melmed S, Colao A, Barkan A et al (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94:1509–1517PubMedCrossRef Melmed S, Colao A, Barkan A et al (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94:1509–1517PubMedCrossRef
5.
go back to reference Cohen P, Clemmons DR, Rosenfeld RG et al (2000) Does the GH-IGF-1 axis play a role in cancer pathogenesis? Growth Horm IGF Res 10: 297–305 Cohen P, Clemmons DR, Rosenfeld RG et al (2000) Does the GH-IGF-1 axis play a role in cancer pathogenesis? Growth Horm IGF Res 10: 297–305
6.
go back to reference Renehan AG, Brennan BM (2008) Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab 22:639–657PubMedCrossRef Renehan AG, Brennan BM (2008) Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab 22:639–657PubMedCrossRef
7.
8.
go back to reference Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom acromegaly study group. J Clin Endocrinol Metab 83:2730–2734PubMedCrossRef Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom acromegaly study group. J Clin Endocrinol Metab 83:2730–2734PubMedCrossRef
9.
go back to reference Terzolo M, Reimondo G, Gasperi M et al (2005) Colonoscopic screening and follow-up inpatients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90:84–90PubMedCrossRef Terzolo M, Reimondo G, Gasperi M et al (2005) Colonoscopic screening and follow-up inpatients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90:84–90PubMedCrossRef
10.
go back to reference Rokkas T et al (2008) Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 14:3484–3489PubMedCrossRef Rokkas T et al (2008) Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 14:3484–3489PubMedCrossRef
11.
go back to reference Cats A et al (1996) Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 56:523–526PubMed Cats A et al (1996) Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 56:523–526PubMed
12.
go back to reference Bogazzi F et al (2003) Changes in the expression of the peroxisome proliferator-activated receptor gamma gene in the colonic polyps and colonic mucosa of acromegalic patients. J Clin Endocrinol Metab 88:3938–3942PubMedCrossRef Bogazzi F et al (2003) Changes in the expression of the peroxisome proliferator-activated receptor gamma gene in the colonic polyps and colonic mucosa of acromegalic patients. J Clin Endocrinol Metab 88:3938–3942PubMedCrossRef
13.
go back to reference Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G et al (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multicenter study. J Endocrinol Invest 25:240–245PubMed Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G et al (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multicenter study. J Endocrinol Invest 25:240–245PubMed
14.
go back to reference Ruchala M, Skiba A, Gurgul E et al (2009) The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Neuro Endocrinol Lett 30:382–386PubMed Ruchala M, Skiba A, Gurgul E et al (2009) The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Neuro Endocrinol Lett 30:382–386PubMed
15.
go back to reference Cheung NW, Boyages SC (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545–549CrossRef Cheung NW, Boyages SC (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545–549CrossRef
16.
go back to reference Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86:2935–2941PubMedCrossRef Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86:2935–2941PubMedCrossRef
17.
go back to reference Pollak M (2008) Insulin, insulin-like growth factors and neoplasia. Best Pract Res Clin Endocrinol Metab 22:625–638PubMedCrossRef Pollak M (2008) Insulin, insulin-like growth factors and neoplasia. Best Pract Res Clin Endocrinol Metab 22:625–638PubMedCrossRef
18.
go back to reference Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221PubMedCrossRef Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221PubMedCrossRef
19.
go back to reference Loeper S, Ezzat S (2008) Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 9:41–58PubMedCrossRef Loeper S, Ezzat S (2008) Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 9:41–58PubMedCrossRef
20.
go back to reference Kasagi K et al (1999) Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland. Thyroid 9:791–796PubMedCrossRef Kasagi K et al (1999) Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland. Thyroid 9:791–796PubMedCrossRef
21.
go back to reference Tita P et al (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 63:161–167CrossRef Tita P et al (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 63:161–167CrossRef
22.
go back to reference Baris D et al (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13:395–400PubMedCrossRef Baris D et al (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13:395–400PubMedCrossRef
23.
go back to reference Kurimoto M et al (2008) The prevalence of benign and malignant tumors in patient with acromegaly at a single institute. Endocr J 55:67–71PubMedCrossRef Kurimoto M et al (2008) The prevalence of benign and malignant tumors in patient with acromegaly at a single institute. Endocr J 55:67–71PubMedCrossRef
24.
go back to reference Gullu BE et al (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13:242–248PubMedCrossRef Gullu BE et al (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13:242–248PubMedCrossRef
25.
go back to reference Vannelli GB et al (1990) Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 71:1175–1182PubMedCrossRef Vannelli GB et al (1990) Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 71:1175–1182PubMedCrossRef
26.
27.
go back to reference Jenkins PJ et al (2000) Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3218–3221PubMedCrossRef Jenkins PJ et al (2000) Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3218–3221PubMedCrossRef
28.
go back to reference Suikkari AM et al (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266–272PubMedCrossRef Suikkari AM et al (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266–272PubMedCrossRef
29.
go back to reference Böni-Schnetzler M (1990) Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol Endocrinol 4:1320–1326PubMedCrossRef Böni-Schnetzler M (1990) Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol Endocrinol 4:1320–1326PubMedCrossRef
31.
go back to reference Brada M et al (1992) Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304:1343–1346PubMedCrossRef Brada M et al (1992) Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304:1343–1346PubMedCrossRef
32.
go back to reference Tsang RW et al (1993) Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 72:2227PubMedCrossRef Tsang RW et al (1993) Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 72:2227PubMedCrossRef
33.
go back to reference Minniti G et al (2005) Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90:800–804PubMedCrossRef Minniti G et al (2005) Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90:800–804PubMedCrossRef
34.
35.
go back to reference Coeli CM et al (2005) Incidência e mortalidade por câncer de tireóide no Brasil. Arq Bras Endocrinol Metab 49:503–509CrossRef Coeli CM et al (2005) Incidência e mortalidade por câncer de tireóide no Brasil. Arq Bras Endocrinol Metab 49:503–509CrossRef
36.
go back to reference Wexler TL et al (2010) Growth hormone status predicts left ventricular mass in patients after cure of acromegaly. Growth Hormon IGF Res 20:333–337CrossRef Wexler TL et al (2010) Growth hormone status predicts left ventricular mass in patients after cure of acromegaly. Growth Hormon IGF Res 20:333–337CrossRef
Metadata
Title
Thyroid cancer in patients with acromegaly: a case–control study
Authors
Maíra Cristina Carvalho dos Santos
Gilvan Cortês Nascimento
Ana Gisélia Cortês Nascimento
Viviane Chaves Carvalho
Maria Honorina Cordeiro Lopes
Renan Montenegro
Renan Montenegro Jr.
Lucio Vilar
Mônica Fiterman Albano
Alice Regina Vasconcelos Alves
Conceição Veiga Parente
Manuel dos Santos Faria
Publication date
01-03-2013
Publisher
Springer US
Published in
Pituitary / Issue 1/2013
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-012-0383-y

Other articles of this Issue 1/2013

Pituitary 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.